iwNHL 2020 Session III
Novel Therapies Part I
Presentations
Novel ADCs
Laurie Sehn
11 September, 2020
CD20 / CD3 bispecific antibodies: How to choose?
Martin Hutchings, MD, PhD, The Finsen Center, National Hospital Copenhagen University Hospital, Copenhagen
11 September, 2020
Oral PI3K delta (δ) inhibitors in lymphoma
Jennifer Brown, MD, PhD, Dana-Farber Cancer Institute, Boston, MA
11 September, 2020
